Phase: Phase IIType: TreatmentAge: 18 and overTrial IDs: CBGJ398X2201, NCI-2014-00150, NCT01975701Phase: Phase IIType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: CBGJ398X2204, NCI-2014-01310, 2013-005085-19, NCT02150967Phase: Phase IIType: TreatmentAge: 18 and overTrial IDs: CBGJ398XUS04, NCI-2014-01999, NCT02160041Phase: Phase IType: TreatmentAge: 18 and overTrial IDs: CBGJ398X2101, NCI-2011-01165, 2009-010876-73, NCT01004224Phase: Phase IType: TreatmentAge: 18 and overTrial IDs: CBGJ398X2102, NCI-2013-01763, NCT01928459
